ERIN WALSH-MULKERRIN: Open Payments
NPI 1598443863 · EAST BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $344 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $262 |
| Madrigal Pharmaceuticals | 1 | $140 |
| HEARTFLOW, INC. | 1 | $133 |
| Hologic Sales and Service, LLC | 1 | $129 |
| Viatris Specialty LLC | 1 | $125 |
| ABBVIE INC. | 3 | $117 |
| GlaxoSmithKline, LLC. | 1 | $109 |
Products named: REZDIFFRA, Yeztugo, FFRct, APTIMA, YUPELRI, Epclusa, BLUJEPA.
Industry payments across MA — which companies pay providers there.
